ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MDNA Medicenna Therapeutics Corp

2.49
0.54 (27.69%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Medicenna Therapeutics Corp MDNA Toronto Common Stock
  Price Change Change Percent Stock Price Last Traded
0.54 27.69% 2.49 16:10:10
Open Price Low Price High Price Close Price Prev Close
2.09 2.09 2.61 2.49 1.95
more quote information »

Recent News

Date Time Source Heading
4/26/202408:16PRNCAL'Organisme canadien de réglementation des investissements..
4/26/202408:14PRNCACanadian Investment Regulatory Organization Trade Resumption..
4/26/202408:09PRNCASuspension de la négociation par l'Organisme canadien de..
4/26/202408:07PRNCACanadian Investment Regulatory Organization Trading Halt -..
4/26/202408:00GLOBEMedicenna Therapeutics Announces CA$20 Million Investment..
4/24/202410:05GLOBEMedicenna Announces Oral Presentation of MDNA11 Data from..
4/10/202406:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
4/09/202416:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
4/09/202412:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
4/04/202407:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
3/06/202407:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
2/14/202407:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
2/13/202407:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
1/12/202417:36GLOBEMedicenna Announces Appointment of New Auditor
1/09/202407:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
12/21/202319:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
12/19/202307:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
11/14/202308:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
11/09/202308:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
11/06/202307:00GLOBEMedicenna Announces Promising Single-Agent Response and..
11/03/202312:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
10/27/202307:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
10/25/202307:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
10/24/202307:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202307:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
10/03/202307:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
9/28/202317:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
9/28/202307:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
9/06/202307:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
8/28/202307:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
8/14/202307:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
8/08/202307:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
8/04/202307:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
8/01/202309:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
7/28/202307:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
7/25/202307:00GLOBEMedicenna Presents at National Brain Tumor Society's..
7/05/202307:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
6/27/202308:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock